Drug-Resistant Tuberculosis (DR-TB) require adequate treatment. Bedaquiline is priority medicine on treatment regimen of DR-TB. Bedaquiline has one of the adverse events is QT intervals prolongation, can increase risk of torsade de pointes (TdP) which can lead to death. DR-TB patient screening before start the treatment and monitoring QT interval during treatment should be done. This study aime…